Loading...
The Tamiflu fiasco and lessons learnt
Oseltamivir (Tamiflu), a neuraminidase inhibitor, was approved for seasonal flu by US Food and Drug Administration in 1999. A number of randomized controlled trials, systematic reviews, and meta-analysis emphasized a favorable efficacy and safety profile. Majority of them were funded by Roche, which...
Na minha lista:
| Udgivet i: | Indian J Pharmacol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Medknow Publications & Media Pvt Ltd
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4375804/ https://ncbi.nlm.nih.gov/pubmed/25821304 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0253-7613.150308 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|